Company
About Axis Bio
Axis Bio is the exclusive U.S. entity of Bioeksen R&D Technologies, a global manufacturer of real-time PCR diagnostic solutions for infectious diseases. Built on a strong foundation of molecular diagnostics expertise, Axis Bio brings advanced multiplex PCR technologies to clinical and research laboratories across the United States.
Our focus is simple: to enable laboratories to operate more efficiently, validate faster, and deliver accurate diagnostic results with confidence. By combining high-performance PCR assays with streamlined workflows and dedicated technical support, we provide laboratories with a complete, end-to-end testing solution — from sample preparation to result interpretation.
Our Approach
At Axis Bio, we go beyond supplying PCR reagents. We work closely with laboratories to support the full implementation of molecular testing workflows.
- Assay selection and test menu optimization
- CLIA validation and verification support
- Workflow integration and efficiency improvements
- Ongoing technical and scientific consultation
Our goal is to act as a long-term partner, helping laboratories successfully adopt and scale molecular testing capabilities.
Powered by Bioeksen R&D
Our solutions are developed and manufactured by Bioeksen R&D Technologies, a globally recognized diagnostics company specializing in real-time PCR platforms and multiplex assay development.
This direct integration between R&D and the U.S. market allows Axis Bio to offer:
Rapid access to innovative assay development
Consistent product quality and supply reliability
Continuous portfolio expansion aligned with emerging clinical needs
Our Mission
Empowering Laboratories
To empower laboratories with reliable, high-performance molecular diagnostic solutions that improve workflow efficiency and support accurate, timely detection of infectious diseases.
Our Vision
A Healthier Future
We envision a future where infectious diseases are diagnosed rapidly, accurately, and at scale — enabling better decisions, improved patient outcomes, and stronger global health systems.